MEGGLE to feature in ‘virtual tour’ of CPhI China in Shanghai
Press Release | MEGGLE Excipients & Technology
JUNE 06, 2017
MEGGLE will be exhibiting in partnership with local partners Guangzhou Standard Pharma Ltd. and Shanghai Pintech Pharmaceutical Co., Ltd. at Booth W5B02 at the Shanghai’s huge SNIEC Exhibition Center.
Organisers UBM Live have selected the MEGGLE stand as one of the highlights of their featured ‘CPhI China New Exhibitors in Excipients Zone Discovery Tour’. This will also include a virtual reality dimension, with VR images of the stand posted to the CPhI website. This will allow a worldwide audience to ‘visit’ the MEGGLE display online.
Ground-breaking lactose excipients
The MEGGLE team led by Dr. Yi Kang, Dr. Xiaolong Chen, Fisher Yu, Raymond Huang and Sophia Yao from the Shanghai Representative Office will be showcasing the wide range of their lactose-based products and co-processed excipients including the ground-breaking Tablettose® and FlowLac® spray-dried alpha-lactose monohydrates, both of which have helped revolutionize direct compression tableting.
MEGGLE will also show Cellactose®, GranuLac® and the InhaLac® inhalation lactose, now strengthened by the addition of micronized InhaLac® 500.
Growing Asian markets
“We are delighted to be returning to Shanghai as an exhibitor and proud to have our display selected to feature as a stop on the New Exhibitors Tour of the Excipients Zone,” said Dr. Yi Kang.
“CPhI China has become a key exhibition for pharmaceutical companies in China and also worldwide and therefore provides a key platform to reach our growing Asian market,” said Dr. Yi.
Video screens on the stand will provide visitors with insights into MEGGLE’s rigorous production standards, advanced technology and pioneering research work.
About MEGGLE Wasserburg
Bavarian-based MEGGLE Wasserburg is one of the world’s foremost experts in lactose and its applications in pharmaceuticals.
From its roots as a dairy operation in the late 1880s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.
MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.
A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for implementation in customer applications, where they can deliver maximum performance.
The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first co-processed excipient to use a hypromellose-lactose base for extended release formulations.
In 2005, MEGGLE opened its FormulaB Centre of Excellence in Odessa, Ukraine, to develop pharmaceutical compounds and manufacture clinical trial materials.
About CPhI China 2017
Since Y2000, CPhI China has established itself as the leading pharma industry business and sourcing event for Eastern Asia, reflecting the huge growth of the Chinese pharma market.
Staged by global B2B events organizer and publisher, UBM Live, CPhI China is a three-day event opening June 20 at the Shanghai New International Exhibition Center (SNIEC).
CPhI China is co-located with five other pharma industry events, P-Mec for machinery and equipment, ICSE for outsourcing solutions BioPh for biotech solution, InnoPack for Drug Packaging and Delivery Technology and LABWorld for laboratory equipment. Together, the shows bring together more than 2,800 suppliers and are likely to attract some 40,000 visitors from more than 100 countries.
CPhI & P-MEC China also part of the wider China Pharma Week, spanning five working days from June 19 that features some 14 events focusing on Business, Knowledge, Leadership, Innovation, Recognition and Networking in the field of Pharma.
More information at http://www.cphi-china.cn/en
Margit Bonnetsmüller, Project Manager Marketing, MEGGLE Excipients &Technology Business Group
Tel: +49 8071 73 476